Search Results - "ARAVAGIRI, M"

Refine Results
  1. 1

    Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia by Gitlin, Michael, Nuechterlein, Keith, Subotnik, Kenneth L., Ventura, Joseph, Mintz, Jim, Fogelson, David L., Bartzokis, George, Aravagiri, Manickam

    Published in The American journal of psychiatry (01-11-2001)
    “…OBJECTIVE: The goal of this report was to examine the clinical course following neuroleptic discontinuation of patients with recent-onset schizophrenia who had…”
    Get full text
    Journal Article
  2. 2

    Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients by Aravagiri, M, Marder, S.R

    “…A liquid chromatography tandem mass spectrometry (LC-MS-MS) assay method for the simultaneous determination of clozapine and its N-desmethyl (norclozapine) and…”
    Get full text
    Journal Article
  3. 3

    Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat by ARAVAGIRI, M, YUWILER, A, MARDER, S. R

    Published in Psychopharmacologia (01-10-1998)
    “…Rats were treated with daily oral doses of 1, 4, and 6 mg/kg risperidone (RSP) and its metabolite, 9-hydroxy-risperidone (9-OH-RSP), for 15 consecutive days…”
    Get full text
    Journal Article
  4. 4

    Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions by Merchant, K M, Dobie, D J, Filloux, F M, Totzke, M, Aravagiri, M, Dorsa, D M

    “…Previous studies have shown elevation of neurotensin neuromedin N (NT/N) and c-fos mRNA in the dorsolateral region of the rat neostriatum (DLSt) by acute…”
    Get more information
    Journal Article
  5. 5

    Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection by Aravagiri, M, Marder, S R, Wirshing, D, Wirshing, W C

    Published in Pharmacopsychiatry (01-05-1998)
    “…A simple, sensitive and accurate method for the simultaneous determination of risperidone (RSP) and its 9-hydroxy metabolite (9-OH-RSP) in human plasma is…”
    Get more information
    Journal Article
  6. 6

    Fluphenazine plasma level monitoring for patients receiving fluphenazine decanoate by Marder, S.R., Aravagiri, M., Wirshing, W.C., Wirshing, D.A., Lebell, M., Mintz, J.

    Published in Schizophrenia research (2002)
    “…Background: Finding a dose of an antipsychotic for maintenance therapy that is both safe and effective can be difficult because clinicians are unable to…”
    Get full text
    Journal Article
  7. 7

    Neuroleptic Plasma Levels by Van Putten, Theodore, Marder, Stephen R, Wirshing, William C, Aravagiri, Manickam, Chabert, Nicole

    Published in Schizophrenia bulletin (1991)
    “…There is enormous variation in plasma levels of most neuroleptics in patients on the same dose. Much of the past research on the relation between plasma levels…”
    Get full text
    Journal Article
  8. 8

    Distribution of Fluphenazine and Its Metabolites in Brain Regions and Other Tissues of the Rat by ARAVAGIRI, M, MARDER, S. R, YUWILER, A, MIDHA, K. K, KULA, N. S, BALDESSARINI, R. J

    Published in Neuropsychopharmacology (New York, N.Y.) (01-11-1995)
    “…Rats were given 5, 10, or 20 mg/kg oral doses of fluphenazine (FLU) dihydrochloride daily for 15 days. FLU and its sulfoxide (FL-SO), 7-hydroxy (7-OH-FLU) and…”
    Get full text
    Journal Article
  9. 9

    Fluphenazine levels during maintenance treatment of recent-onset schizophrenia : relation to side effects, psychosocial function and depression by GITLIN, M. J, NUECHTERLEIN, K. H, MINTZ, J, FOGELSON, D, BARTZOKIS, G, VENTURA, J, SUBOTNIK, K, ARAVAGIRI, M

    Published in Psychopharmacologia (01-03-2000)
    “…The utility of fluphenazine levels during maintenance treatment of schizophrenia is still unclear. This study investigated the relationship between…”
    Get full text
    Journal Article
  10. 10

    Chronic haloperidol-induced changes in regional dopamine release and metabolism and neurotensin content in rats by See, R.E., Lynch, A.M., Aravagiri, M., Nemeroff, C.B., Owens, M.J.

    Published in Brain research (18-12-1995)
    “…Chronic neuroleptic administration has previously been shown to alter in vivo measures of dopaminergic function and lead to regionally selective increases in…”
    Get full text
    Journal Article
  11. 11

    Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response by Marder, S R, Midha, K K, Van Putten, T, Aravagiri, M, Hawes, E M, Hubbard, J W, McKay, G, Mintz, J

    Published in British journal of psychiatry (01-05-1991)
    “…The levels of fluphenazine and fluphenazine sulphoxide in schizophrenic patients who were randomly assigned to receive either 5 mg or 25 mg of fluphenazine…”
    Get more information
    Journal Article
  12. 12

    Metabolism of phenothiazine and butyrophenone antipsychotic drugs. A review of some recent research findings and clinical implications by Hubbard, J W, Midha, K K, Hawes, E M, McKay, G, Marder, S R, Aravagiri, M, Korchinski, E D

    Published in British journal of psychiatry. Supplement (01-12-1993)
    “…Whereas some metabolites of antipsychotic drugs are psychoactive and contribute to clinical improvement, recent studies have provided evidence that certain…”
    Get more information
    Journal Article
  13. 13

    Synthesis of the N-oxides of phenothiazine antipsychotic agents by Jaworski, T J, Sardessai, M S, Aravagiri, M, Lin, G, Shi, Y Y, Hawes, E M, Hubbard, J W, McKay, G, Midha, K K

    Published in Journal of pharmaceutical sciences (01-03-1993)
    “…Chlorpromazine N-oxide, fluphenazine N4'-oxide, prochlorperazine N4'-oxide, sulforidazine N-oxide, and trifluoperazine N4'-oxide were synthesized by oxidation…”
    Get more information
    Journal Article
  14. 14

    Pharmacokinetics and tissue distribution of olanzapine in rats by Aravagiri, Manickam, Teper, Yaroslav, Marder, Stephen R.

    Published in Biopharmaceutics & drug disposition (01-11-1999)
    “…The single dose pharmacokinetics of olanzapine in rats, following an oral dose and its distribution in the brain and other tissues after repeated oral and…”
    Get full text
    Journal Article
  15. 15

    Clinical perspectives of some neuroleptics through development and application of their assays by Midha, K K, Marder, S R, Jaworski, T J, McKay, G, Hubbard, J W, Hawes, E M, Van Putten, T, Wirshing, W C, Aravagiri, M

    Published in Therapeutic drug monitoring (01-06-1993)
    “…Attempts to investigate relationships between plasma levels of neuroleptics and therapeutic outcome in schizophrenic patients have been hampered due to such…”
    Get more information
    Journal Article
  16. 16

    Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to rats by ARAVAGIRI, Manickam, MARDER, Stephen R

    Published in Psychopharmacologia (01-02-2002)
    “…Following an oral dose of risperidone (RSP), concentrations of its major metabolite 9-hydroxyrisperidone (9-OHRSP) were high in plasma and tissues but…”
    Get full text
    Journal Article
  17. 17

    Simultaneous determination of risperidone and 9-hydroxyrisperidone in plasma by liquid chromatography/electrospray tandem mass spectrometry by Aravagiri, Manickam, Marder, Stephen R.

    Published in Journal of mass spectrometry. (01-06-2000)
    “…A simple and highly sensitive liquid chromatographic/electrospray tandem mass spectrometric (LC/MS/MS) assay was developed for the simultaneous determination…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Therapeutic monitoring of steady-state plasma levels of the N4'-oxide metabolite of fluphenazine in chronically treated schizophrenic patients determined by a specific and sensitive radioimmunoassay by Aravagiri, M, Marder, S R, Van Putten, T, Hawes, E M, McKay, G, Hubbard, J W, Midha, K K

    Published in Therapeutic drug monitoring (01-05-1990)
    “…Highly specific and sensitive antisera for fluphenazine-N4'-oxide (FLUNO) were obtained from New Zealand white rabbits immunized with a bovine serum albumin…”
    Get more information
    Journal Article
  20. 20

    Development and application of a specific radioimmunoassay for trifluoperazine N4'-oxide to a kinetic study in humans by Aravagiri, M, Hawes, E M, Midha, K K

    “…A hapten derivative of prochlorperazine N4'-oxide, 7-(3-carboxy-propionyl)-prochlorperazine N4'-oxide, was synthesized and coupled to bovine serum albumin…”
    Get more information
    Journal Article